Tashkent Pharma Park, Tashkent, Uzbekistan Global Standards. Local Strength. Better Healthcare.
GRANDENEPHARMACEUTICALS

Manufacturing

Manufacturing built for quality and scale.

Our facility

Manufacturing Built for Quality and Scale

Grandene's manufacturing program is designed around modern pharmaceutical engineering principles, controlled workflows and robust quality systems. The objective is to create reliable manufacturing capability that can support local market needs, product localization and future international opportunities.

753,000sq ft
Manufacturing site
8
Production lines
7
Dosage forms
400+
Employees
3.77bn
Units per year

Dosage forms

Dosage-form capabilities

Eight production lines cover oral solid dosage forms, softgels, semi-solids and suppositories.

01

Tablets

Oral solid dosage tablets produced through controlled, reproducible processes.

3.165 bn units / year

02

Capsules

Hard capsules designed for accurate, consistent oral dosing.

369 mn units / year

03

Sachets

Powders and granules in single-dose sachets for convenient administration.

18 mn units / year

04

Effervescent tablets

Moisture-sensitive effervescent tablets requiring tightly controlled environments.

05

Softgel capsules

Soft capsules for liquid and semi-solid formulations.

180 mn units / year

06

Ointments & creams

Semi-solid topical preparations for dermatological use.

9 mn units / year

07

Suppositories

Suppositories manufactured with precise moulding and temperature control.

30 mn units / year

8

Production lines

Contact Us

Production capacity

Built for scale: billions of doses a year

Grandene's annual production capacity by dosage form, across eight production lines at Tashkent Pharma Park.

Total annual capacity
3.77
billion units per year

Annual design capacity by dosage form.

  • Tablets 3.165 bnunits / year 83.9% of total capacity
  • Capsules 369 mnunits / year 9.8% of total capacity
  • Softgel capsules 180 mnunits / year 4.8% of total capacity
  • Suppositories 30 mnunits / year 0.8% of total capacity
  • Sachets 18 mnunits / year 0.5% of total capacity
  • Ointments & creams 9 mnunits / year 0.2% of total capacity

Philosophy

Our manufacturing philosophy

01

Logical personnel and material flows

02

Controlled manufacturing environments appropriate to the process

03

Process consistency and reproducibility

04

Validated systems and qualified equipment, as applicable

05

Documentation and traceability throughout manufacturing

06

Quality risk management

07

Data integrity and controlled records

08

Continuous improvement and operational discipline

Technology

International technology, local expertise

Our production floor and laboratories bring together equipment and instrumentation from leading manufacturing nations — operated by a growing team of Uzbek pharmaceutical professionals.

Manufacturing equipment

Production machinery from established equipment manufacturers in three countries.

  • India
  • China
  • South Korea

Laboratory instruments

Analytical and laboratory instrumentation from five leading manufacturing nations.

  • USA
  • Germany
  • Japan
  • United Kingdom
  • India

Designed for Partnership

Grandene intends to support product localization and technology-transfer programs with partners seeking reliable manufacturing capability in Uzbekistan. Partnership models may include technology transfer, local manufacturing, contract manufacturing and other structures subject to technical, regulatory and commercial assessment.